...
首页> 外文期刊>Leukemia >High levels of the adhesion molecule CD44 on leukemic cells generate acute myeloid leukemia relapse after withdrawal of the initial transforming event
【24h】

High levels of the adhesion molecule CD44 on leukemic cells generate acute myeloid leukemia relapse after withdrawal of the initial transforming event

机译:撤回初始转化事件后,白血病细胞上高水平的粘附分子CD44会导致急性髓细胞白血病复发

获取原文

摘要

Multiple genetic hits are detected in patients with acute myeloid leukemia (AML). To investigate this further, we developed a tetracycline-inducible mouse model of AML, in which the initial transforming event, overexpression of HOXA10, can be eliminated. Continuous overexpression of HOXA10 is required to generate AML in primary recipient mice, but is not essential for maintenance of the leukemia. Transplantation of AML to secondary recipients showed that in established leukemias, ~80% of the leukemia-initiating cells (LICs) in bone marrow stopped proliferating upon withdrawal of HOXA10 overexpression. However, the population of LICs in primary recipients is heterogeneous, as ~20% of the LICs induce leukemia in secondary recipients despite elimination of HOXA10-induced overexpression. Intrinsic genetic activation of several proto-oncogenes was observed in leukemic cells resistant to inactivation of the initial transformation event. Interestingly, high levels of the adhesion molecule CD44 on leukemic cells are essential to generate leukemia after removal of the primary event. This suggests that extrinsic niche-dependent factors are also involved in the host-dependent outgrowth of leukemias after withdrawal of HOXA10 overexpression event that initiates the leukemia.
机译:在患有急性髓细胞性白血病(AML)的患者中检测到多种基因突变。为了进一步研究,我们开发了AML的四环素诱导小鼠模型,可以消除HOXA10的初始转化事件。为了在原代受体小鼠中产生AML,需要持续过量表达HOXA10,但这对于维持白血病不是必需的。将AML移植到继发受体中后发现,在已建立的白血病中,HOXA10过表达退出后,骨髓中约80%的白血病起始细胞(LIC)停止增殖。但是,主要受体中的LIC人群是异质的,因为尽管消除了HOXA10诱导的过表达,但约有20%的LIC在次级受体中诱导白血病。在抗初始转化事件失活的白血病细胞中观察到了几种原癌基因的内在遗传激活。有趣的是,白血病细胞上高水平的粘附分子CD44对于去除原发事件后产生白血病至关重要。这表明在停止引发白血病的HOXA10过表达事件后,外源性利基依赖性因子也参与了白血病的宿主依赖性生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号